Nevertheless, increasing evidence suggests that a subset of sinonasal adenocarcinomas expresses immune checkpoint molecules such as PD-L1 and displays tumor-infiltrating lymphocytes, supporting the rationale for immunotherapeutic intervention. The gene discussed is CD274; the disease is neoplasm.